GSK vs NVS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jun 30, 2026
GSK
NVS
Investment Advisor Scores
NVS
Jun 30, 2026AI Analyst Insights
Detailed Metrics Comparison
| Metric | GSK | NVS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 22.0751 | 17.6056 | NVS |
| PEG Ratio | 19.8724 | 4.1905 | NVS |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 1.5% | -0.7% | GSK |
| Earnings Growth | 8.4% | -9.3% | GSK |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 64.1/100 | 66.2/100 | NVS |
| Profit Margin | 17.8% | 23.9% | NVS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
| Implied Volatility | N/A | N/A | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | BUY | BUY | Tie |